Search
for
Sort by
Research 61–90 of 1000+
- Comparison of clinical trials with finasteride and dutasteride.
- Androgenetic alopecia: An autosomal dominant disorder
- THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH
- Phytotherapy in Trichology: A Review
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Anti-androgens for the treatment of hirsutism
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- Steven Kossards postmenopausal frontal fibrosing alopecia (PFFA)--a therapeutic dilemma.
- The Dutasteride: Miraculous Drug in Alopecia Treatment A Review
- Guideline for the primary care management of male lower urinary tract symptoms
- Common urologic diseases in older men and their treatment: how they impact fertility
- Serenoa repens (saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Effects of 5-alpha reductase inhibitors
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 9 Role of 5α-reductase in health and disease
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- The connection of 5-alpha reductase inhibitors to the development of depression